EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted delivery of FAK siRNA by engineered exosomes to reverse cetuximab resistance via activating paraptosis in colon cancer

Yiting Geng, Wei Xia, Xiao Zheng, Lujun Chen, You Zhou, Jun Feng, Ye Yuan, Mingyue Zhang, Jianwen Lu, Shanshan Wei, Wenwei Hu

Apoptosis · 2024

DOI: 10.1007/s10495-024-01986-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Apoptosis, 2024. Verfasst von Yiting Geng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Third Affiliated Hospital of Soochow University, 185 Juqian Street, Changzhou, 213003, China. Hauptthemen laut MEDLINE: Cetuximab, Exosomes, Drug Resistance, Neoplasm, Colonic Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Changzhou "14th Five-Year Plan" High-level Health Personnel Training Project, The Role of Beta-glucans in Regulating the Intratumoral Microbiota of Colorectal Adenomatous Polyps.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cetuximab is extensively used in the treatment of metastatic colorectal cancer (mCRC). However, resistance poses a significant challenge to successful therapy. Recently, paraptosis, a non-classical programmed cell death, has garnered increased attention for its potential application value in antitumor treatments. We aimed to identify the essential pathways and signaling molecules involved in paraptosis inhibition and select them as therapeutic targets in cetuximab resistance. Additionally, engineered exosome technology is used as a drug delivery system with both targeted and effector properties.

Results

By comparing the differential expression of paraptosis-related genes between drug-resistant colon cancer cells and sensitive cells, it was observed that the paraptosis level induced by cetuximab was significantly downregulated in drug-resistant cells. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis identified the focal adhesion kinase (FAK) signaling pathway as a key pathway involved in the suppression of paraptosis. The biological function of FAK in cetuximab-resistant cells was investigated through cell morphology observation, CCK-8 assay, colony formation assay, RT-qPCR, Western Blot, and loss-of-function experiments. The results showed that the FAK signaling pathway was significantly upregulated in cetuximab-resistant colon cancer cells, and siRNA interference targeting FAK could notably inhibit cell proliferation while upregulating the paraptosis level. Based on this, engineered colon cancer cells targeted and FAK siRNA loaded exosomes (CT-Exo-siFAK1) were constructed. In vitro experiments, CT-Exo-siFAK1 could effectively activate paraptosis and inhibit the proliferation of drug-resistant colon cancer cells. In vivo experiments also confirmed that CT-Exo-siFAK1 significantly suppressed tumor growth and metastasis while upregulating the paraptosis level.

Conclusion

This study suggests that FAK signaling pathway-mediated inhibition of paraptosis levels is crucial in the sensitivity of cetuximab targeted therapy in colon cancer, and the use of engineered exosomes to deliver FAK siRNA may be an effective strategy to reverse cetuximab resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CetuximabExosomesDrug Resistance, NeoplasmColonic NeoplasmsRNA, Small InterferingHumansAnimalsCell Line, TumorMiceSignal TransductionFocal Adhesion Kinase 1Xenograft Model Antitumor AssaysApoptosisMice, NudeCell ProliferationMice, Inbred BALB CDrug Delivery SystemsGene Expression Regulation, NeoplasticAntineoplastic Agents, ImmunologicalParaptosis

Stichwörter der Autor:innen

Cetuximab resistanceColorectal cancerEngineered exosomeFAKParaptosis

Substanzen

CetuximabRNA, Small InterferingFocal Adhesion Kinase 1PTK2 protein, humanAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of Oncology, The Third Affiliated Hospital of Soochow University, 185 Juqian Street, Changzhou, 213003, China.
  • Jiangsu Engineering Research Center for Tumor Immunotherapy, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, China.
  • Tumor Biological Diagnosis and Treatment Center, the Third Affiliated Hospital of Soochow University, Changzhou, 213003, China.
  • Institute of Cell Therapy, Soochow University, Changzhou, 213003, China.
  • Department of Oncology, The Third Affiliated Hospital of Soochow University, 185 Juqian Street, Changzhou, 213003, China. huwenwei@suda.edu.cn.
  • Jiangsu Engineering Research Center for Tumor Immunotherapy, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, China. huwenwei@suda.edu.cn.

Förderung

  • the National Natural Science Foundation of China
  • Changzhou "14th Five-Year Plan" High-level Health Personnel Training Project
  • The Role of Beta-glucans in Regulating the Intratumoral Microbiota of Colorectal Adenomatous Polyps

Zitieren

APA

Geng, Y., Xia, W., Zheng, X., Chen, L., Zhou, Y., Feng, J., Yuan, Y., Zhang, M., Lu, J., Wei, S., & Hu, W. (2024). Targeted delivery of FAK siRNA by engineered exosomes to reverse cetuximab resistance via activating paraptosis in colon cancer. Apoptosis. https://doi.org/10.1007/s10495-024-01986-x

Vancouver

Geng Y, Xia W, Zheng X, Chen L, Zhou Y, Feng J, et al. Targeted delivery of FAK siRNA by engineered exosomes to reverse cetuximab resistance via activating paraptosis in colon cancer. Apoptosis. 2024. doi:10.1007/s10495-024-01986-x

BibTeX
@article{Geng2024,
  author = {Geng, Yiting and Xia, Wei and Zheng, Xiao and Chen, Lujun and Zhou, You and Feng, Jun and Yuan, Ye and Zhang, Mingyue and Lu, Jianwen and Wei, Shanshan and Hu, Wenwei},
  title = {Targeted delivery of FAK siRNA by engineered exosomes to reverse cetuximab resistance via activating paraptosis in colon cancer},
  journal = {Apoptosis},
  year = {2024},
  doi = {10.1007/s10495-024-01986-x}
}
Kostenlos starten →